Monitoring of Fetal Lung Elasticity by Elastography Between 24 and 39 Weeks

The objective of the study is to evaluated the evolution of the LLE ratio (Lung to Liver Elastography ratio) during normal pregnancy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pregnant Woman

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

CHU Jean Minjoz

Besançon, Doubs, 25000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

major pregnant women
singleton pregnancy

Exclusion criteria

foetus:

fetal pulmonary disease
fetal liver disease
chromosome fetal abnormalities
fetal growth restriction

mother:

BMI>30 in beginning of pregnancy
premature ruptured membranes
high blood pressure
pre-eclampsia
gestational diabetes

Treatment and study plan

lung and liver elastography measurement of fetus

Other

Other: lung and liver elastography measurement of fetus

Primary outcomes

Change of Lung to liver Elastography ratio (LLE ratio) between 24 and 39 weeks of amenorrhea

Time frame: measurements at: 24, 28, 32, 36, 39 weeks of amenorrhea (WA)

Evolution of the fetal lung elasticity coefficient measured in kilopascals (kPa) compared to the fetal liver elasticity

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Besancon

Other

Registry information

Acronym: ELASTOPULM

Important dates

Study start: 2019
Primary completion: 2019
Study completion: 2021
First posted: Feb 8, 2019
Registry last updated: Mar 5, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed